Mysterious Metformin

被引：35

作者：

Chong, Curtis R. ^{[2
]}

Chabner, Bruce A. ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

来源：

ONCOLOGIST | 2009年 / 14卷 / 12期

关键词：

BREAST-CANCER CELLS; DIABETES-MELLITUS; PANCREATIC-CANCER; INSULIN GLARGINE; IN-VITRO; RISK; METAANALYSIS; GROWTH; KINASE; EPIDEMIOLOGY;

D O I：

10.1634/theoncologist.2009-0286

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1178 / 1181

页数：4

共 46 条

[1]

[Anonymous], GLUC

[2] Drug therapy - Metformin [J].

Bailey, CJ ;

Turner, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579

[3] Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis [J].

Barone, Bethany B. ;

Yeh, Hsin-Chieh ;

Snyder, Claire F. ;

Peairs, Kimberly S. ;

Stein, Kelly B. ;

Derr, Rachel L. ;

Wolff, Antonio C. ;

Brancati, Frederick L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (23) :2754-2764

[4] The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J].

Ben Sahra, I. ;

Laurent, K. ;

Loubat, A. ;

Giorgetti-Peraldi, S. ;

Colosetti, P. ;

Auberger, P. ;

Tanti, J. F. ;

Le Marchand-Brustel, Y. ;

Bost, F. .

ONCOGENE, 2008, 27 (25) :3576-3586

[5] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].

Bowker, SL ;

Majumdar, SR ;

Veugelers, P ;

Johnson, JA .

DIABETES CARE, 2006, 29 (02) :254-258

[6] Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth [J].

Buzzai, Monica ;

Jones, Russell G. ;

Amaravadi, Ravi K. ;

Lum, Julian J. ;

DeBerardinis, Ralph J. ;

Zhao, Fangping ;

Viollet, Benoit ;

Thompson, Craig B. .

CANCER RESEARCH, 2007, 67 (14) :6745-6752

[7] Is it Time to Test Metformin in Breast Cancer Clinical Trials? [J].

Cazzaniga, Massimiliano ;

Bonanni, Bernardo ;

Guerrieri-Gonzaga, Aliana ;

Decensi, Andrea .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (03) :701-705

[8] Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group [J].

Colhoun, H. M. .

DIABETOLOGIA, 2009, 52 (09) :1755-1765

[9] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes [J].

Currie, C. J. ;

Poole, C. D. ;

Gale, E. A. M. .

DIABETOLOGIA, 2009, 52 (09) :1766-1777

[10] When "Flawed" Translates into "Flood": The Unproven Association Between Cancer Incidence and Glargine Insulin Therapy [J].

de Miguel-Yanes, Jose M. ;

Meigs, James B. .

ONCOLOGIST, 2009, 14 (12) :1175-1177

← 1 2 3 4 5 →